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Aims. People with psychotic disorders face impairments in their global functioning and their 
quality of life (QoL). The relationship between the two outcomes has not been systematically 
investigated. Through a systematic review we aim to explore the presence and extent of 
associations between global functioning and QoL and establish whether associations depend 
on the instruments employed.  
Methods. In May 2016, 10 electronic databases were searched using a two-phase process to 
identify articles in which associations between global functioning and QoL were assessed. 
Basic descriptive data and correlation coefficients between global functioning and QoL 
instruments were extracted, with strength of the correlation assessed according to the 
specifications of Cohen 1988. Results were reported with reference to the Meta-analysis of 
Observational Studies in Epidemiology (MOOSE) guidelines and PRISMA standards. A 
narrative synthesis was performed due to heterogeneity in methodological approaches. 
Results. Of an initial 15,183 non-duplicate articles identified, 756 were deemed potentially 
relevant, with 40 studies encompassing 42 articles included. 14 instruments for measuring 
global functioning and 22 instruments for measuring QoL were used. 29 articles reported 
linear associations while 19 assessed QoL predictors. Correlations between overall scores 
varied in strength, primarily dependent on the QoL instrument employed, and whether QoL 
was objectively or subjectively assessed. Correlations observed for objective QoL measures 
were consistently larger than those observed for subjective measures, as were correlations for 
interviewer than self-assessed QoL. When correlations were assessed by domains of QoL, the 
highest correlations were found for social domains of QoL, for which most correlations were 
moderate or higher. Global functioning consistently predicted overall QoL as did depressive 
and negative symptoms. 
Conclusions. This review is the first to explore the extent of associations between global 
functioning and QoL in people with psychotic disorders. We consistently found a positive 
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association between global functioning and QoL. The strength of the association was 
dependent on the QoL instrument employed. QoL domains strongly associated with global 
functioning were highlighted. The review illustrates the extensive array of instruments used 
for the assessment of QoL and to a lesser extent global functioning in people with psychotic 
disorders, and provides a framework to understand the different findings reported in the 
literature. The findings can also inform the future choice of instruments by researchers and/or 
clinicians. The observed associations reassure that interventions for improving global 
functioning will have a positive impact on the QoL of people living with a psychotic disorder. 
 
Key words: Schizophrenia, Psychosis, Functioning, Quality of life.  
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Introduction 
Psychotic disorders are of special interest due to the severity of their symptoms, the 
surrounding stigma and the consequences of dysfunction, discrimination and costs. The 
importance of functioning to psychotic disorders was reaffirmed when psychosis was 
described as an imprecise group of symptoms, of sufficient severity to disrupt everyday 
functioning (Petho & Ban, 1988).  
According to the International Classification of Functioning, Disability and Health 
(World Health Organization, 2001), functioning denotes the positive features of the 
relationship between a health condition and the environmental and personal context of the 
individual, while disability indicates negative features of that relationship. Thus, functioning 
is concerned with the ability of an individual to perform their roles and participate in life 
(Bowling, 2005). Global functioning should encompass the measurement of several types of 
functioning (Aas, 2010). Since 1962, a number of instruments have been created to measure 
global functioning, as well as specific dimensions (or types) of functioning e.g., social 
functioning, executive functioning, etc. (see Fig. 1). 
Almost parallel to the development of instruments to assess functioning, and shortly 
after quality of life (QoL) in health care was raised by Elkinton, when he asked: “What is the 
harmony within a man, and between a man and his world –the quality of life– to which the 
patient, the physician, and society aspires?” (Elkinton, 1966), interest in QoL as an outcome 
of people with psychosis began to emerge (Fig. 1). This interest occurred alongside the 
implementation of community support programmes after deinstitutionalization (Baker & 
Intagliata, 1982, Lehman, 1988). QoL has been defined as “an individual’s perception of their 
position in life in the context of the culture and value systems in which they live and in 
relation to their goals, expectations, standards and concerns” (World Health Organization, 
1997). Despite this, there is no agreement on what aspects and how QoL should be assessed. 
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More than 50 QoL instruments have been used in patients with mental disorders (Prigent et 
al., 2014).  
<Please insert Figure 1 around here> 
 Functioning and more recently QoL have thus been identified as important outcomes 
in people with psychosis. Reviews focused on the assessment of global functioning and QoL 
in people with psychotic disorders are scarce (Awad et al., 1997, Pinikahana et al., 2002) and 
the relationship between them has not been systematically assessed. As impairment in global 
functioning of people with psychosis is expected, it is important to understand the impact of 
this impairment on QoL. Establishing the relationship between global functioning and QoL 
measures would support the future choice of instruments for the assessment of these 
outcomes and, in turn, identify strategies to diminish the societal burden of psychotic 
disorders. 
 The aim of the present study is to explore the presence and extent of associations 
between global functioning and QoL in people with psychotic disorders and establish whether 




This systematic review was conducted in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) (Moher et al., 2009). Studies included for 
data extraction were full text articles with a cross-sectional design or a follow-up design that 
provided required information at baseline. Baseline information only was sought, as changes 
in the functioning of people with psychosis over time is well documented (Ascher-Svanum, 
2013, Harvey, 2014, Harvey & Davidson, 2002). Articles could be written in English or 
Spanish (given native English and Spanish speakers within the authorship team). The sample 
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needed to comprise people with schizophrenia and schizophrenia spectrum disorders with or 
without people with mood disorders with psychotic symptoms (bipolar disorder type I, major 
or severe depressive disorder with psychotic symptoms) assessed according to the 
Ninth/Tenth Revision of the International Classification of Diseases (ICD 9/10) or the 
Diagnostic and Statistical Manual of Mental Disorders Fourth/Fifth Edition (DSM-IV/5), and 
aged between 18 and 64 years, in which associations between global functioning and QoL 
were assessed. There were no time-period restrictions. 
 Due to the lack of a universal definition of global functioning, instruments that 
assessed several dimensions of functioning as an inclusive outcome were deemed a global 
functioning instrument. Likewise, given the absence of a universally accepted definition of 
QoL, instruments reporting on a group of outcomes that contribute to an individual’s 
satisfaction with life and/or overall health (Fayers & Machin, 2016) were accepted for 
inclusion in the review.  
 Intervention studies, reviews and meta-analyses were excluded as well as studies 
based on populations with organic or induced psychosis, psychosis due to other mental 
disorders or other medical conditions and populations at high risk of psychosis but not yet 
diagnosed. Intervention studies were excluded as functioning levels differ in artificial 
environments such as clinical trials (Ascher-Svanum, 2013, Bellack et al., 2007, Patterson et 
al., 2001).  
 
Search strategy 
In May 2016 Annual Reviews, Cochrane Library, CINAHL, EconLit, Embase, Medline, 
PsycARTICLES, PsycINFO, PubMed and ScienceDirect were searched using a two-phase 
identification process. Search terms were introduced with corresponding MeSH Terms, 
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synonyms and stem words, as well as appropriate filters and use of Boolean operators. The 
detailed search strategy is available as Supplementary material. 
 Searches were divided into phases in order to identify potential publication bias. This 
approach was adopted because of concern that only strong associations would be reported in 
title and abstract. In Phase A, all keyword terms were searched in title and abstract. In Phase 
B, all keyword terms except functioning were searched in title and abstract, with stem 
“function” then searched for in the main text. 
 
Study selection 
Two independent reviewers (ANF and AN) assessed studies for inclusion, with 
inconsistences and disagreements resolved by consensus. After deletion of duplicates, Phase 
A records were screened for inclusion criteria in their titles and abstracts. Full-text articles of 
included studies were obtained and assessed in full for eligibility. A similar process was used 
for Phase B records, except that screening for inclusion included a search for functioning in 
the main text. Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) statement (von Elm et al., 2007) was used to assess whether analytical 
observational studies reported STROBE elements determined a priori as essential. These 




Data extracted from each article encompassed basic descriptive data and correlation 
coefficients between global functioning and QoL instruments. Extraction was undertaken by 
ANF under the guidance of AN. After extraction, socio-demographic variables were coded 
for summarization in frequency tables. 
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The correlation coefficients between global functioning and QoL extracted were; 
correlations between global functioning and other variables; and correlations between QoL 
and other variables comprising the domains and items covered for each instrument. This 
analysis reports on the strength of the correlation between global functioning and QoL and 
between global functioning and individual domains of QoL. Strength of correlation was 
assessed according to the specifications of Cohen 1988 (Cohen, 1988) established as 0.10 ≤ r 
< 0.3 small effect, 0.3 ≤ r < 0.5 medium effect and 0.50 ≤ r large effect. 
 A narrative synthesis was performed given heterogeneity in methodological 
approaches, including instruments employed in the assessment of global functioning and 
QoL, and statistical analyses employed. QoL instruments were defined as objective, if 
comprised of objective items only (usually intended for interviewer-assessment), subjective if 
comprised of subjective items only (usually intended for self-assessment), or subjective and 
objective. Results were reported with reference to the Meta-analysis of Observational Studies 




Across Phases A and B 15,183 records were initially identified, of which 8,673 were 
duplicates and excluded from further review. In Phase A, upon screening of title and abstract, 
637 articles were then assessed as requiring full text review for eligibility, with 34 articles 
assessed as eligible. In Phase B upon screening of title and abstract, 2,601 articles were 
assessed as requiring full-text screening for functioning, with 119 then identified as requiring 
full-text review for eligibility. Eight additional articles were identified as eligible for 
inclusion (see Fig. 2). Thus 42 articles were included in this review as listed in Table 1. 
<Please insert Figure 2 around here> 
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The articles  
Articles were published between 1997 and 2016, all met the required STROBE criteria for 
inclusion. Three-fifths (25 articles) were from Europe. Four articles related to the European 
Psychiatric Services: Inputs Linked to Outcome Domains and Needs (EPSILON) study: Gaite 
et al. (2002) and Becker et al. (2005) reported on the entire sample while Meijer et al. (2002) 
reported on the Amsterdam participants at baseline, and at 18 months follow up (2009), as 
part of a broader Netherlands’ study. Each of these articles undertook different analyses of 
the data and as there was no pooling of results, the results for each are reported to maximise 
the comprehensiveness of the narrative synthesis. Four more articles (Brissos et al., 2011, 
Holloway & Carson, 1999, Hunter & Barry, 2012, Kusel et al., 2007) were published as part 
of larger studies. The systematic review thus comprised articles from 40 independent studies.  
 
Data extracted overview  
The median number of participants across all studies was 135, with the range 36 to 971. 
Schizophrenia was the single diagnosis in 26 articles (62%), only four articles (Greenley et 
al., 1997, Holloway & Carson, 1999, Lasebikan & Owoaje, 2015, Stubbs et al., 2015) (10%) 
included participants with bipolar disorder or depressive disorder with psychotic symptoms. 
Over half of the articles (57%) utilized one instrument for measuring functioning and one for 
measuring QoL. Six articles, employed two functioning instruments, 11 articles two QoL 
instruments and one article (Reine et al., 2005) three QoL instruments. Fujino et al. (2016) 
utilized two instruments, which together assessed global functioning.  
 Within the included studies we identified 14 instruments for measuring global 
functioning and 22 for QoL. The Global Assessment of Functioning (GAF) was the most 
utilized functioning instrument (29 articles) and the WHO Quality of Life abbreviated version 
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(WHOQOL-BREF) together with its Portuguese version the most utilized QoL instrument 
(12 articles) (see Supplementary material).  
Of the 42 articles, 29 (69%) reported linear associations between global functioning 
and QoL overall scores and/or domain scores and presented correlation coefficients, four 
articles (10%) assessed associations between global functioning and QoL using alternate 
statistical methods; and 19 articles (45%) assessed predictors of QoL (Table 2). Outcomes for 
each are examined below. 
 
Linear associations between global functioning and QoL (overall scores) 
20 articles (48%) provided correlations between overall scores of global functioning and QoL 
instruments. Two of these articles (Bai et al., 2014, Mas-Exposito et al., 2011) also provided 
correlations between global functioning with QoL domains and among global functioning 
and QoL domains (Table 2). 
Correlations between overall scores ranged in strength from strong to weak with 
nearly half of the correlations reported as moderate (r=0.34 to 0.49). Most moderate 
correlations involved the GAF which is consistent with the frequent use of the instrument. 
The two largest correlations assessed QoL using the Quality of Life Scale (QLS), the largest 
assessed functioning with the Personal and Social Performance (PSP) (r=0.84), the second 
largest with the GAF (r=0.83). The smallest correlation reported as significant were for the 
GAF and the Quality of Life Questionnaire (QLQ) and the GAF and Manchester Short 
Assessment of Quality of Life (MANSA) (r=0.16 for each) (Fig. 3). 
<Please insert Figure 3 around here> 
 Amongst the QoL instruments, nearly one-third of the correlations were assessed in 
relation to the QLS primarily the complete 21-item version, with the 7-item and 5-item 
versions also assessed in Ritsner et al. (2005). Half the correlations were large, including that 
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for the 7-item version. One-quarter of correlations were assessed in relation to the self-
assessed WHOQOL-BREF. Correlations were reported for four domain scores and two 
separate scored items that assessed the individual’s overall perception of QoL and health 
(University of Washington, 2011, World Health Organization, 1998) in Galuppi et al. (2010), 
and just for overall QoL in three articles (Bai et al., 2014, Chino et al., 2009, Ito et al., 2015). 
Some articles reported correlations for the four domains and a total score (Bai et al., 2014, 
Mas-Exposito et al., 2011, Miclutia et al., 2008). Ito et al. (2015) reported non-significant 
associations for the overall score in insidious onset and acute onset (r=-0.24, -0.21) 
respectively. Correlations observed for objective QoL measures such as QLS, were 
consistently larger (r=0.20 to 0.84) than those observed for subjective measures such as 
WHOQOL-BREF (r=-0.21 to 0.58). Interviewer-assessment was also associated with larger 
correlations than self-assessment as reflected in Riedel et al. (2011). 
 
Linear association between overall scores of global functioning and QoL domains 
Thirteen articles (31%) provided correlations between global functioning and QoL domains, 
as listed in Table 3. Global functioning was measured with GAF in over half of the articles 
(62%), and with the exception of Bai et al. (2014) which employed the self-reported version 
of the graphic PSP (SRG-PSP), the interviewer undertook all assessments of functioning. The 
most utilized QoL instrument was the WHOQOL-BREF, followed by the Medical Outcomes 
Study 36-Item Short-Form Health Survey (SF-36). Assessments of QoL were self-assessed, 
with four exceptions (Meijer et al., 2002, Reine et al., 2005, Riedel et al., 2011, Rocca et al., 
2014). 
In total we recorded 100 correlation coefficients across 39 domains within included 
QoL instruments. Strength of correlations varied widely and were primarily weak (48%). Just 
over one-quarter of correlations were presented in a single article (Reine et al., 2005), with 
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the GAF compared to three different QoL instruments, the SF-36, Schizophrenia Quality of 
Life (S-QoL) and Lehman’s Quality of Life Interview brief version (QoLI brief) (subjective 
items). All associations reported in this study were weak, and in some instances lower than 
for other comparable assessments.  
The largest correlation coefficient (r=0.72) was between functioning assessed with 
GAF and “subjective wellbeing” assessed by the interviewer with the Riedel-Spellmann-
Musil-Scale (RSM-Scale) (Riedel et al., 2011). The next four highest correlations were also 
assessed between these instruments (r=0.61 to 0.65) (Riedel et al., 2011). The smallest 
significant correlation (r=0.10) was between functioning assessed with GAF and interviewer-
assessed “mental and physical health” of the QoLI brief, subjective items only (Reine et al., 
2005).  
Most correlations between global functioning and QoL domains were positive. 
Exceptions were for Mas-Exposito et al. (2011), which employed the WHO Short Disability 
Assessment Schedule (WHO DAS-S) for evaluating functioning, and Fujino et al. (2016) and 
Kuo et al. (2009), which employed the Schizophrenia Quality of Life Scale Japanese version 
(JSQLS) and Revision 4 Chinese version (SQLS-R4) to assess QoL respectively. For each of 
these three instruments lower scores signify better outcomes. 
Correlations for the WHOQOL-BREF tended to be larger than those for the SF-36. 
The WHOQOL-BREF gave rise to correlations that were primarily moderate in strength for 
each of the four domains of the instrument, although large correlations were also reported for 
the physical (Galuppi et al., 2010) and psychological domains (Miclutia et al., 2008). In 
regard to the SF-36, of the 24 correlations all were small except for four correlations from 
two of three articles: one correlation for the physical domain (Dima et al., 2015), one for the 
mental health domain (Meijer et al., 2002) and two for the social domain (Dima et al., 2015, 
Meijer et al., 2002). 
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The three most frequently assessed domains of quality of life were the physical, 
psychological and social components. The vast majority of correlations for the physical 
component were small (70%), half were small for the psychological component and 45% 
small for the social component. Around a third of these small correlations were assessed in 
Reine et al. (2005) which reported just over a quarter of all correlations. Over half (56%) of 
the correlations reported for occupational and environmental issues, as well as for 
components related to treatment and satisfaction with life in general were small.  
When correlations were limited to broad domains (i.e., included several items), over 
half of the correlations were moderate for the environmental, psychological and social 
components, and small for over half the correlations for physical components. 
Over two thirds of the total correlations between global functioning and QoL domains 
were self-assessed and nearly half were small (r=-0.03 to 0.29). The remaining 29 
correlations were interviewer-assessed and over half were small (r=0.10 to 0.21). 
 
Associations resulting from alternate statistical approaches 
In the four articles assessing associations between global functioning and QoL using alternate 
statistical methods four separate approaches were used. Mubarak (2005) which compared 
means of dysfunction with a dichotomisation of QoL found that people with high dysfunction 
(low functioning) had low QoL. Pitkanen et al. (2012) which compared medians of QoL with 
a dichotomisation of functioning reported that lower functioning indicated poorer QoL. 
Becker et al. (2005) which compared means of QoL across three levels of functioning 
showed an increase in mean of QoL across levels of functioning from low to high. Medeiros-
Ferreira et al. (2013) which compared means of HRQoL and functioning in subgroups of 
people with or without metabolic syndrome reported no association.  
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Functioning as predictor of QoL 
19 articles (45%) assessed predictors of QoL. Of these, Fujino et al. (2016) and Rocca et al. 
(2014) did not include global functioning as an initial predictor, 13 modelled global 
functioning as a predictor in their final models and four (Adewuya & Makanjuola, 2009, 
Gaite et al., 2002, Kuo et al., 2009, Razali & Wahid, 2012) did not include it in the final 
models (Table 2). 
 Of the 13 articles that modelled global functioning as a predictor of QoL, nine 
considered QoL overall and three specific domains of QoL. Woon et al. (2010) tested both. 
Global functioning predicted QoL overall in most analyses (Alessandrini et al., 2016, Kusel 
et al., 2007, Lasebikan & Owoaje, 2015, Meijer et al., 2009, Norman et al., 2000, Rocca et 
al., 2016, Roe et al., 2011, Woon et al., 2010). Exceptions were Stubbs et al. (2015) and 
Prince (2007).  
 
Discussion 
This systematic review is the first to explore the presence and extent of associations between 
global functioning and QoL in people with psychotic disorders. The appraisal proved difficult 
given a lack of similarities between studies, and differences in methodological approaches 
including instruments employed, and inconsistencies in results for given instruments. Despite 
these difficulties, we found that most of the included articles reported positive associations 
between higher global functioning and better QoL, and through a narrative review we were 
able to clarify the extent of these associations alongside important explanatory factors. 
Our results showed that the strength of the association was primarily dependent on the 
QoL instrument used and whether QoL was being objectively or subjectively assessed. The 
largest correlations were given by objective QoL instruments completed by an interviewer, 
the RSM-Scale in particular. The RSM-Scale covers social, occupational and psychological 
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functioning and includes physical functioning and subjective well-being (Riedel et al., 2011). 
The other objective QoL instrument, the QLS, covers social (interpersonal relations), 
occupational (instrumental role) and psychological domains (intrapsychic foundations) as 
well as common objects and activities (Heinrichs et al., 1984). Thus, domains covered by 
both objective QoL instruments, overlap with domains encompassed by measures of global 
functioning, which account for the strong associations observed. Furthermore both, objective 
QoL instruments and measures of global functioning were assessed by the one interviewer 
leading to further consistency in assessment. In contrast, subjective QoL instruments are 
intended to be completed through self-assessment and given that the patient’s perspective can 
differ from an evaluator’s (Atkinson et al., 1997, Bengtsson-Tops et al., 2005, Sainfort et al., 
1996), the resulting differences will affect the strength of the correlation. 
 Even with the application of the same instruments, correlation coefficients will vary 
as a result of sampling variation. This was evident for studies that used the GAF and 
MANSA (Kusel et al., 2007, Roe et al., 2011). A smaller correlation was found when 
participants were all living in a psychiatric rehabilitation residential facility in Israel (Roe et 
al., 2011), than recruited from inpatient and outpatient settings in the United Kingdom (Kusel 
et al., 2007). Likewise, the importance of country and in turn differences in cultural and 
possibly health system structure and functioning is arguably reflected in Hosseini and 
Yousefi (2011). Two thirds of participants in this study lived in an Iranian institution, and 
while QoL was measured with an objective QoL instrument (QLS), a small correlation was 
assessed. In comparison strong to moderate associations were assessed in other studies using 
the QLS from Europe (Hunter & Barry, 2012, Karadayi et al., 2011, Kusel et al., 2007, 
Nafees et al., 2012), Canada (Norman et al., 2000) and Israel (Ritsner et al., 2005).  
Variation in QoL of people living with psychosis based on sociodemographic 
characteristics is well documented (Browne, 1996, Caron et al., 2005, Chan et al., 2003). 
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Ethnicity has also been acknowledged as a contributor to the QoL of people with psychosis 
within a given cultural setting (Ben-Zur et al., 2014, Lehman, 1995), which may in part be 
due to the impact of racism and discrimination on an individual’s expectations (Lehman, 
1995, Prince, 2007). Religious beliefs and spirituality may also contribute directly to a better 
QoL (Caqueo-Urízar et al., 2016, Cohen et al., 2010, Grover et al., 2014). It is thus evident 
that social and demographic issues will affect associations between global functioning and 
QoL of people living with psychosis. 
Our results support respondent burden as a potential confounder in the assessment of 
associations between functioning and QoL (Fricker et al., Ulrich et al., 2005). We observed 
small correlations only when three QoL instruments were employed (Reine et al., 2005), as 
predominantly small correlations when two QoL instruments were employed (Dima et al., 
2015, Meijer et al., 2002). 
We also observed that some authors (Bai et al., 2014, Mas-Exposito et al., 2011, 
Miclutia et al., 2008) reported a total score for the WHOQOL-BREF when there is no such 
approved score for this instrument. The WHOQOL-BREF generates four domain scores and 
two separately scored items (overall perception of QoL and health) (University of 
Washington, 2011, World Health Organization, 1998). As the appropriate use of an 
instrument is essential for a valid outcome, all results pertaining to the WHOQOL-BREF 
total score are not considered reliable. In another study (Medeiros-Ferreira et al., 2013), 
standard scoring techniques for the EQ-5D were not applied. Reine et al. (2005) reported the 
physical and mental composite scores of the SF-36, and while assessed (Ware Jr et al., 1995), 
it has been suggested they provide an imprecise summary of profile scores (Taft et al., 2001). 
For these reasons, results of these studies were not considered reliable, reinforcing the 
importance of the proper use of an instrument, and the necessity of adhering to standardised 
scoring protocols. 
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Another important finding was that the domains covered by an instrument are key to 
the associations obtained. Further, the items included within an instrument will lead to 
differences in correlations as reflected in the results for the three variations of the QLS (the 
complete 21 items and abbreviated 7 and 5 items). We consider that in the assessment of QoL 
of people with psychosis it is important to include items that broadly encompass the mental 
or psychological domain, otherwise the outcome will not fully reflect the potential 
experiences of this population. Thus, the assessment of mental health in the EQ-5D is 
considered problematic given that the dimension is comprised of a single item regarding the 
presence of anxiety and/or depression. In turn, while moderate correlations were obtained 
between the EQ-5D and global functioning, correlations themselves should not be considered 
sufficient in determining a reliable and valid QoL instrument. 
Findings regarding the strength of the associations between global functioning and 
QoL domains highlighted social components. These had the highest correlations, with more 
than half moderate or higher even when subjectively assessed. However, the breadth of 
domains also impacted correlations, and were smaller for narrow domains. As with 
comparisons between overall scores, the QoL instrument was the primary determinant of the 
strength of the correlations between global functioning and QoL domains.  
Our systematic review has highlighted the extensive array of instruments for the 
assessment of QoL, and to a lesser extent global functioning in people living with a psychotic 
disorder. Further, given that both outcomes are commonly used, our systematic review 
provides the framework to understand the different findings reported in the literature, and 
inform the future choice of instruments by researchers and/or clinicians.  
We found no patterns in the use of instruments in regard to either year, country where 
studies were conducted, diagnostic criteria or other characteristics. This variability could be 
in part due to the absence of a universal definition of global functioning and QoL. However, 
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the diversity is likely at least in part driven by cultural issues leading to modification of 
available instruments. Also limiting study findings was the need to undertake a narrative 
review given the heterogeneity of study findings. We did not include articles published in 
other than English or Spanish. All articles identified employed English, although over three-
quarters were from non-English speaking countries. Therefore it is considered that this 
limitation will have minimal impact if any on our findings. We did not register our protocol 
with PROSPERO: International prospective registered systematic reviews (University of 
York, 2011) as we considered our review fell under stated exclusion criteria: “looking at the 
reporting of and/or use of outcomes in research would not be included”.  
We believe that clearer and precise definitions of global functioning and QoL are 
required so these outcomes can be concisely and uniformly measured, and we can identify the 
domains of life that need to be targeted for improving these outcomes. Further, only by 
having standard/homogeneous instruments, can we consistently assess the impact of 
interventions aimed at improving these outcomes, and thereby contribute to the ongoing 
development and implementation of strategies for improving global functioning and QoL in 
people living with psychotic disorders.  
Overall, most articles identified reported moderate and positive associations between 
global functioning and QoL. The strength of correlation was dependent upon the instruments 
employed and the respondent (e.g., a clinician or the individual living with psychosis). 
However, the moderate associations between global functioning and QoL reassure that 
interventions that improve functioning in people with a psychotic disorder will have a 
positive impact on their QoL. Policy makers and clinicians should make improvement of QoL 
of people with psychosis a priority alongside symptom remission. Happiness and satisfaction, 
fulfilment of goals and expectations, are essential to people living with psychotic illness. 
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Fig. 1. Timeline of functioning and quality of life instruments development. 
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Fig. 2. PRISMA flow diagram of Phase A and Phase B search.  
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Fig. 3. Correlations between global functioning and quality of life. 
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Table 1. Main characteristics of included studies 
  Country of Participants  Instruments 
Study Conducted publication N Age range Dxa (%) Functioning Quality of Life 
Greenley et al. (1997) NA USA 971 NA NS GAF QLQ 
ELCCT: Holloway & Carson (1999) NA England 70 NA NS WHO/DAS LQOLP; LEC 
Norman et al. (2000) 1989-1993 Canada 128 17-57 100 LSP QLS; GWB 
EPSILON:  
Gaite et al. (2002) 
Becker et al. (2005) 
1997-1998 Denmark; England; 
Italy; Spain;       
The Netherlands 
404 18-65 NS GAF LQoLP-EU (European version) 
Meijer et al. (2009, 2002) 1997-1998 The Netherlandsb 143 18-65 100 GAF SF-36; LQoLP Dutch version 
Mubarak (2005) NA Malaysia 258 NA 100 WHO/DAS QoLI 
Reine et al. (2005) 2000 France 205 18-70 100 GAF SF-36; QoLI brief version; S-QoL 
Ritsner et al. (2005) NA Israel 133 18-60 100 GAF QLS; Q-LES-Q 
König et al. (2007) 2003-2004 Germany 166 21-80 72 GAF; SOFAS EQ-5D; WHOQOL-BREF 
UK-SCAP: Kusel et al. (2007) 1999-2000 United Kingdom 442 NA NS GAF QLS; MANSA 
Prince (2007) 1994-1996 USA 264 17-65 NS GAS QoLI 
Miclutia et al. (2008) NA Romania 50 18-55 100 GAF WHOQOL-BREF 
Adewuya & Makanjuola (2009) 2006 Nigeria 99 NA 100 GAF WHOQOL-BREF 
Chino et al. (2009) NA Japan 36 NA 100 GAF WHOQOL-BREF 
Kuo et al. (2009) NA Taiwan 100 18-65 100 GAF SQLS-R4; LQOLP Taiwanese  
Galuppi et al. (2010) 2008 Italy 104 NA 100 FPS WHOQOL-BREF 
Woon et al. (2010) NA Singapore 83 NA 100 GAF WHOQOL-BREF 
PSP Portuguese validation 
study: Brissos et al. (2011) 




Hosseini &Yousefi (2011) 1999-2000 Iran 100 21-60c 100 GAF QLS 
Karadayi et al. (2011) NA Turkey 102 18-65 100 PSP QLS 
Mas-Exposito et al. (2011) 2006-2008 Spain 241 NA 100 GAF; WHO 
DAS-S 
WHOQOL-BREF 
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  Country of Participants  Instruments 
Study Conducted publication N Age range Dxa (%) Functioning Quality of Life 
Riedel et al. (2011) 2007 Germany 136 18-65 78 GAF QLS; RSM-Scale 
Roe et al. (2011) 2007-2008 Israel 159 19-66 NS GAF MANSA 
Guilera et al. (2012) 2007-2009 Spain 352 18-55 88 WHODAS II; 
SOFAS 
EQ-5D 
EGOFORS: Hunter & Barry 
(2012) 





295 NA 100 GAF; PSP QLS 
Nafees et al. (2012) NA United Kingdom 73 18-65 100 PSP; GAF QLS 
Pitkanen et al. (2012) 2005-2006 Finland 311 18-65 41 GAF EQ-5D; Q-LES-Q short form 
Razali & Wahid (2012) NA Malaysia 206 18-60 100 PSP QoLI brief version 
Medeiros-Ferreira et al. (2013) 2008-2009 Spain 76 NA NS GAF EQ-5D 
Akinsulore et al. (2014) 2010 Nigeria 100 NA 100 GAF WHOQOL-BREF 
Bai et al. (2014) NA Taiwan 108 20-60 100 PSP; SRG-PSP WHOQOL-BREF 
Rocca et al. (2014) 2009-2011 Italy 92 18-65 100 PSP QLS 
Zendijidjian et al. (2014) NA France 91 NA 100 GAF SF-36 
Dima et al. (2015) 2009-2010 Romania 131 18-65 NS GAF SF-36; Q-LES-Q short form 
Ito et al. (2015) 2008-2011 Japan 168 16-55 NS GAF WHOQOL-BREF 
Lasebikan & Owoaje (2015) 2008 Nigeria 652 NA 56 GAF WHOQOL-BREF 
Stubbs et al. (2015) 2010-2012 United Kingdom 438 NA NS GAF EQ-5D 3 levels 
Alessandrini et al. (2016) 2010-2014 France 271 NA 100 FROGS S-QoL 18 
Fujino et al. (2016) NA Japan 93 NA 100 UPSA-B; SFS JSQLS 
Rocca et al. (2016) 2008-2011 Italy 323 18-65 100 GAF QLS 
NA, not available; NS, not specified; USA, United States of America; ELCCT, East Lambeth Continuing Care Team study; EPSILON, European Psychiatric 
Services: Inputs Linked to Outcome Domains and Needs study; UK-SCAP, United Kingdom Schizophrenia Care and Assessment Programme; EGOFORS, 
European Group on Functional Outcomes and Remission in Schizophrenia study; GAF, Global Assessment of Functioning; WHO/DAS, World Health 
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Organization Disability Assessment Schedule; LSP, Life Skills Profile; SOFAS, Social and Occupational Functioning Assessment Scale; GAS, Global 
Assessment Scale; FPS, Personal and Social Functioning Scale; PSP, Personal and Social Performance scale; WHO DAS-S, World Health Organization Short 
Disability Assessment Schedule; SRG-PSP, Self-reported version of the graphic PSP; FROGS, Functional Remission Of General Schizophrenia; UPSA-B, 
University of California, San Diego (UCSD) Performance-based Skills Assessment-Brief version; SFS, Social Functioning Scale; QLQ, Quality of Life 
Questionnaire; LQOLP, Lancashire Quality of Life Profile; LEC, Life Experiences Checklist; QLS, Quality of Life Scale; GWB, General Well-Being Scale; 
SF-36, Medical Outcomes Study (MOS) 36-Item Short-Form Health Survey; QoLI, Lehman’s Quality of Life Interview; S-QoL, Schizophrenia Quality of 
Life; Q-LES-Q, Quality of Life Enjoyment and Satisfaction Questionnaire; EQ-5D, EuroQol five dimensions questionnaire; WHOQOL-BREF, World Health 
Organization Quality of Life abbreviated version; MANSA, Manchester Short Assessment of Quality of Life; SQLS-R4, Schizophrenia Quality of Life Scale 
Revision 4 Chinese version; RSM-Scale, Riedel-Spellmann-Musil-Scale; JSQLS, Schizophrenia Quality of Life Scale Japanese version. 
a Percentage of schizophrenia diagnosis. 
b Including EPSILON’s participants from Amsterdam and other participants from The Netherlands. 
c Lower – Upper age of participants included in the study. 
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Table 2. Summary of associations provided by article 
Articles (total 42) N % References 
Correlations    
Overall global functioning– Overall quality of life (QoL) 20 48 Karadayi et al. (2011), Mas-Exposito et al. (2011), Riedel et al. (2011), 
Hosseini& Yousefi (2011), Roe et al. (2011), Hunter& Barry (2012), 
Nafees et al. (2012), Gaite et al. (2002), Reine et al. (2005), König et al. 
(2007), Kusel et al. (2007), Miclutia et al. (2008), Galuppi et al. (2010), 
Dima et al. (2015), Chino et al. (2009), Greenley et al. (1997), Ritsner et 
al. (2005), Norman et al. (2000), Bai et al. (2014), Ito et al. (2015). 
Overall global functioning – Domains of QoL 13 31 Mas-Exposito et al. (2011), Riedel et al. (2011), Meijer et al. (2002), 
Reine et al. (2005), Miclutia et al. (2008), Galuppi et al. (2010), Rocca 
et al. (2014), Dima et al. (2015), Kuo et al. (2009), Woon et al. (2010), 
Akinsulore et al. (2014), Bai et al. (2014), Fujino et al. (2016). 
Domains of global functioning – Overall QoL 5 12 Mas-Exposito et al. (2011), Guilera et al. (2012), Holloway& Carson 
(1999), Chino et al. (2009), Bai et al. (2014). 
Domains of global functioning– Domains of QoL 5 12 Mas-Exposito et al. (2011), Rocca et al. (2014), Alessandrini et al. 
(2016), Bai et al. (2014), Fujino et al. (2016). 
Alternate statistical methods 4 10 Mubarak (2005), Pitkanen et al. (2012), Becker et al. (2005), Medeiros-
Ferreira et al. (2013). 
Associations estimated by multivariate analysis  
Global functioning – Overall QoL 10 24 Roe et al. (2011), Meijer et al. (2009), Kusel et al. (2007), Stubbs et al. 
(2015) Alessandrini et al. (2016), Rocca et al. (2016), Norman et al. 
(2000), Woon et al. (2010), Prince (2007), Lasebikan& Owoaje (2015). 
Global functioning – Domains of QoL 4 10 Brissos et al. (2011), Zendjidjian et al. (2014), Woon et al. (2010), 
Akinsulore et al. (2014). 
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Galuppi et al 
(2010) 
Bai et al. 
(2014) 
Fujino et al. 
(2016) 
Kuo et al. 
(2009) 
Dima et al. 
(2015) 
Reine et al 
(2005) 
Meijer et al. 
(2002) 
Riedel et al. 
(2011) 
Rocca et al. 
(2014) 
 
Instruments GAF GAF GAF     WHODAS-S    FPS SRG-
PSP 
UPSA-B GAF GAF GAF GAF GAF PSP 
QoL domains 
(number of items) 






















Environment (8) 0.34♦ 0.19 0.42** -0.36♦ 0.43♦ 0.39**        
Living conditions (11)       
(RSM Sub_3)            
0.26♦ 
0.47♦e  
Living situation (4)           0.04   
Residence (3)          0.07b    
Finances (4)           0.11   
Disposable income (3)          -0.05b    
Personal security (3)          0.10b    









Subjective wellbeing  (16) 
(RSM Sub_1)            
0.36♦ 
0.72♦e  
Life satisfaction (1)         0.23*     
Goals (Fulfilment) (13)           0.21**   
Framework (10)           0.14   
Symptoms/Side Effects (8)       -0.34**       







l Occupational functioning (8)            
0.34♦ 
0.59♦e  
Instrumental role (4)             0.44♦ 
Job satisfaction (3)          -0.10b    
Common Objects and activities (2)             0.17 
Leisure activities (4)          0.12b    




















Galuppi et al 
(2010) 
Bai et al. 
(2014) 
Fujino et al. 
(2016) 
Kuo et al. 
(2009) 
Dima et al. 
(2015) 
Reine et al 
(2005) 
Meijer et al. 
(2002) 
Riedel et al. 
(2011) 
Rocca et al. 
(2014) 
 
Instruments GAF GAF GAF     WHODAS-S    FPS SRG-
PSP 
UPSA-B GAF GAF GAF GAF GAF PSP 
QoL domains 
(number of items) 















 Psychological (6) 0.31
♦ 0.42** 0.58** -0.31♦ 0.34* 0.39**        
 Psychological wellbeing (10)          0.26
c♦    








Composite Mental score          0.21a**    
Resilience (5)          0.26c♦    
Emotional functioning (10)            0.35
♦ 
0.65♦e  
Role Emotional (3)         0.12a* 0.17a* 0.25a**   
Self-esteem (6)          0.24c♦     
Negative esteem (5)            0.35**   
Positive esteem (5)           0.21*   






Health (7)           0.33**   
Health (1)     0.30*         
General Health Perceptions (5)          0.15a* 0.20a*   
Physical Health (7) 0.29** 0.42** 0.29** -0.30♦ 0.57  ͋ 0.44**        
Physical functioning (10)         0.40a** 0.14a 0.28a**   
Physical functioning (7)            0.22
♦ 
 0.41♦e  
Physical well-being (4)          0.21c♦    
Role physical (4)         0.20a** 0.18a* 0.26a**   
Composite physical score          0.14a    
Cognition (4)            0.28
♦ 
0.61♦e  
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(2014) 
 
Instruments GAF GAF GAF     WHODAS-S    FPS SRG-
PSP 
UPSA-B GAF GAF GAF GAF GAF PSP 
QoL domains 
(number of items) 















Autonomy (4)          0.28c♦    
Energy/Fatigue (4)         0.21a** 0.24a♦ 0.17a*   
Motivation energy (7)       -0.16 -0.11      
Bodily Pain (2)          0.15a* 0.19a**   





Interpersonal relationships (8)             0.56♦ 
Social relationships (3) NP 0.21* 0.47** -0.31♦ 0.37* 0.37**        
Social relations (3)          0.20b**    
Functioning in social roles (9) 
(RSM Sub_2)             
0.35♦ 
 0.65♦e  
Social functioning (7)            0.38
♦ 
0.65♦e  
Social functioning (2)         0.32a** 0.18a* 0.37a**   
Sentimental life (2)          0.23c♦    
Leisure and social (6)           0.18*   
Friends relationships (5)          0.16c*    
Family relationships (5)          0.09c    
Family relations (2)           0.12   
Family relations (2)          -0.05b    
*p<0.05, **p<0.01,   ͋p<0.005, ♦p<0.001 
Note: Quality of life domains were extracted from each of the QoL instruments. The number of items for the assessment of every domain are within parenthesis. 
NP, not provided. 
b QoLI brief. Only subjective items were used. 
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d RSM-scale allocates their 36 items into five-dimensions model, it also assigns the items to three sub scores: Items 1-16 (Sub_1), items 17-20, 23, 32-35 (Sub_2), items 21-
22, 24-31, 36 (Sub_3). 
e Interviewer-assessment. 
 
 
 
 
 
 
 
 
 
 
 
